TRIP4 and lung cancer: Experiments have demonstrated that activation of the MAPK and EGFR signaling pathways can increase the resistance of cervical and lung cancer cells to radiation, respectively, and knockout of thyroid hormone receptor interactor 4 (TRIP4) promotes the inactivation of MAPK signaling, which effectively improves the sensitivity of the former to radiation [43,44].